NIH scientists find weak points on Epstein-Barr virus
New details of EBV protein could aid treatment, prevention efforts
2024-03-12
(Press-News.org) WHAT:
Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus. The research was led by Jeffrey I. Cohen, M.D., and colleagues from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Study findings were published in the journal Immunity.
Approximately 95% of the world’s population is infected with EBV, which remains in the body permanently, typically in B lymphocytes, which are antibody-producing immune system cells, and cells lining the throat and pharynx. EBV can sometimes lead to B-cell cancers, including Burkitt, Hodgkin and non-Hodgkin lymphomas, or to gastric or nasopharyngeal cancers. Recently, EBV infection was shown to significantly raise the risk of developing multiple sclerosis. There is no vaccine to prevent EBV infection nor a specific treatment.
In this study, NIAID investigators examined a viral protein called gp42, which the virus must use to infect B cells. Theoretically, a vaccine or antibody-based treatment capable of blocking gp42’s ability to bind to or fuse with B cells would prevent EBV infection and, thus, the virus’s ability to persist in those cells. The team generated two gp42-specific mAbs, A10 and 4C12, and used X-ray crystallography to visualize how they interacted with gp42. The crystal structures revealed that the two mAbs interacted with distinct, non-overlapping sites on gp42. Monoclonal antibody A10 blocked the site on gp42 required for receptor binding, while 4C12 interfered with a different site that is involved in membrane fusion.
Next, the scientists tested A10, 4C12 and several other mAbs in mice for their ability to prevent EBV infection and EBV lymphomas. The mAb A10 provided nearly complete protection against EBV infection and none of the mice developed lymphoproliferative disease or lymphoma. In contrast, nearly all the mice treated with other mAbs became infected and some developed lymphoproliferative disease or lymphoma.
If future studies show mAb A10 to be safe and effective in humans, it could have clinical applications, particularly in people who have not been infected with EBV; those with immunodeficiency conditions, including severe combined immunodeficiency; or people receiving transplants. People with such conditions are at risk of developing severe or fatal cases of EBV disease during their initial encounter with the virus. The investigational monoclonal antibody could potentially be used prophylactically to prevent or better control EBV infections in such cases, the investigators note.
Additionally, the study team suggests that identification of the vulnerable sites on gp42 also paves the way to designing future vaccines that could elicit antibodies against one or both of the newly described sites.
ARTICLE:
W Bu et al. Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells. Immunity DOI: 10.1016/j.immuni.2024.02.008 (2024).
WHO:
Dr. Cohen, Chief, Laboratory of Infectious Diseases, NIAID, is available to comment.
CONTACT:
To schedule interviews, please contact NIAID News and Science Writing Branch, (301) 402-1663, NIAIDNews@niaid.nih.gov.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit https://www.nih.gov/.
NIH...Turning Discovery Into Health®
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-03-12
DURHAM, N.C. -- It might look like a roll of chicken wire, but this tiny cylinder of carbon atoms -- too small to see with the naked eye -- could one day be used for making electronic devices ranging from night vision goggles and motion detectors to more efficient solar cells, thanks to techniques developed by researchers at Duke University.
First discovered in the early 1990s, carbon nanotubes are made from single sheets of carbon atoms rolled up like a straw.
Carbon isn’t exactly a newfangled material. All life on Earth is based on carbon. ...
2024-03-12
UNIVERSITY PARK, Pa. — Poor sleep habits are strongly associated with long-term chronic health conditions, according to decades of research. To better understand this relationship, a team led by researchers in Penn State’s College of Health and Human Development identified four distinct patterns that characterize how most people sleep. These patterns are also predictive of long-term health, the researchers said.
Soomi Lee, associate professor of human development and family studies at Penn State, ...
2024-03-12
This year, City of Hope doctors and scientists will also present data during AACR’s Press Program and a clinical trials plenary session:
Monday, April 8, 2024, at 8:30 a.m.
Research by Ajay Goel, Ph.D., M.S., City of Hope professor and chair, Department of Molecular Diagnostics and Experimental Therapeutics, and Caiming Xu, Ph.D., a postdoctoral fellow in Goel’s lab, will be presented at an AACR press conference. The abstract is titled “An exosome-based liquid biopsy for non-invasive, early detection of patients with pancreatic ductal adenocarcinoma: A multicenter ...
2024-03-12
Extracytoplasmic function sigma factors (ECFs) have been successfully used for constructing predictable artificial gene circuits bacteria like Escherichia coli, but their transferability between species within the same phylum remained unknown. Now, a recent study by a group of researchers from Germany and Australia explored the bacteria Sinorhizobium meliloti and identified ECF switches with cross-species functionality, constructed genetic circuits, and provided a toolbox for universal synthetic biology applications.
In the field of synthetic biology, creating artificial gene circuits with predictable outcomes is both a challenge and a necessity. Extracytoplasmic function sigma factors ...
2024-03-12
Background and objectives
Cannabis is a commonly used recreational and therapeutic substance in our society. There are a variety of established physical, social, and mental health impacts associated with cannabis use. However, there is no overview of the impact cannabis use has on the genitourinary system. Thus, this scoping review aims to present data on the impact of cannabis on the genitourinary system.
Methods
A scoping review search was undertaken on Embase, Medline, and Web of Science. There were no date restrictions ...
2024-03-12
SAN ANTONIO — March 12, 2024 — Southwest Research Institute has developed off-road autonomous driving tools with a focus on stealth for the military and agility for space and agriculture clients. The vision-based system pairs stereo cameras with novel algorithms, eliminating the need for lidar and active sensors.
“We reflected on the toughest machine vision challenges and then focused on achieving dense, robust modeling for off-road navigation,” said Abe Garza, a research engineer in SwRI’s Intelligent Systems Division.
Through internal research, SwRI engineers developed a suite of tools known as the Vision for Off-road Autonomy (VORA). The passive ...
2024-03-12
Key Takeaways
A collaborative study between bariatric and transplant teams has created a viable pathway for patients with obesity who also have end-stage renal disease to become eligible for kidney transplants through weight loss surgery.
Postoperative outcomes indicate significant improvements in BMI, hypertension, and diabetes management, enhancing patients’ overall health and transplant viability.
High drop-off rates emphasize the need for enhanced patient ...
2024-03-12
WASHINGTON, March 12, 2024 – Sometimes, seeing clearly requires complete black. For astronomy and precision optics, coating devices in black paint can cut down on stray light, enhancing images and boosting performance. For the most advanced telescopes and optical systems, every little bit matters, so their manufacturers seek out the blackest blacks to coat them.
In the Journal of Vacuum Science & Technology A, by AIP Publishing, researchers from the University of Shanghai for Science and Technology and the Chinese Academy of Sciences developed an ultrablack thin-film coating for aerospace-grade magnesium alloys. Their coating absorbs 99.3% of light while being ...
2024-03-12
About The Study: The results of a nationally representative 2023 survey indicate that Δ8- tetrahydrocannabinol (THC) use prevalence is appreciable among adolescents and is higher in states without marijuana legalization or existing Δ8-THC regulations. Prioritizing surveillance, policy, and public health efforts addressing adolescent Δ8-THC use may be warranted.
Authors: Adam M. Leventhal, Ph.D., of the University of Southern California in Los Angeles, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.0865)
Editor’s Note: Please see the ...
2024-03-12
About The Study: In this observational, target trial emulation analysis that included 148,000 individuals diagnosed with attention-deficit/hyperactivity disorder (ADHD) in Sweden, initial dispensation of ADHD medication was significantly associated with lower all-cause and unnatural-cause mortality, whereas the association with natural-cause mortality was not significant.
Authors: Zheng Chang, Ph.D., and Lin Li, Ph.D., of the Karolinska Institutet in Stockholm, are the corresponding authors.
To ...
LAST 30 PRESS RELEASES:
[Press-News.org] NIH scientists find weak points on Epstein-Barr virus
New details of EBV protein could aid treatment, prevention efforts
